These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28753307)

  • 1. Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
    Fonseca A; Reis J; Silva T; Matos MJ; Bagetta D; Ortuso F; Alcaro S; Uriarte E; Borges F
    J Med Chem; 2017 Aug; 60(16):7206-7212. PubMed ID: 28753307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
    Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
    Costas-Lago MC; Besada P; Rodríguez-Enríquez F; Viña D; Vilar S; Uriarte E; Borges F; Terán C
    Eur J Med Chem; 2017 Oct; 139():1-11. PubMed ID: 28797881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors.
    Reis J; Cagide F; Chavarria D; Silva T; Fernandes C; Gaspar A; Uriarte E; Remião F; Alcaro S; Ortuso F; Borges F
    J Med Chem; 2016 Jun; 59(12):5879-93. PubMed ID: 27244485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies.
    Bhawna ; Kumar A; Bhatia M; Kapoor A; Kumar P; Kumar S
    Eur J Med Chem; 2022 Nov; 242():114655. PubMed ID: 36037788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs.
    Gnerre C; Catto M; Leonetti F; Weber P; Carrupt PA; Altomare C; Carotti A; Testa B
    J Med Chem; 2000 Dec; 43(25):4747-58. PubMed ID: 11123983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
    Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
    Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the discovery of a novel class of monoamine oxidase inhibitors: structure-property-activity and docking studies on chromone amides.
    Gaspar A; Teixeira F; Uriarte E; Milhazes N; Melo A; Cordeiro MN; Ortuso F; Alcaro S; Borges F
    ChemMedChem; 2011 Apr; 6(4):628-32. PubMed ID: 21442758
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of MAO-B inhibitors - present status and future directions part I: oxygen heterocycles and analogs.
    Helguera AM; Perez-Machado G; Cordeiro MN; Borges F
    Mini Rev Med Chem; 2012 Sep; 12(10):907-19. PubMed ID: 22420569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses and Evaluation of 2- or 3-(N-Cyclicamino)chromone Derivatives as Monoamine Oxidase Inhibitors.
    Takao K; Sakatsume T; Kamauchi H; Sugita Y
    Chem Pharm Bull (Tokyo); 2020; 68(11):1082-1089. PubMed ID: 33132375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F
    Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Quezada E; Picciau C; Delogu G; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3268-70. PubMed ID: 19423346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.